Paper326384
The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
Bonadonna G and 4 others. Cancer, 1977. Cited by 265 papers, by iCite.
Cite this record
ConductScience Library. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Papers, record 326384. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326384
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Cyclophosphamide | Major topic |
| Fluorouracil | Major topic |
| Methotrexate | Major topic |
| Amenorrhea | |
| Clinical Trials as Topic | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Leukopenia | |
| Lymphatic Metastasis | |
| Mastectomy | |
| Menopause | |
| Middle Aged | |
| Thrombocytopenia |
Source PubMed
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 265 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26123412 | Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer. | BMC Surg | 2015 | https://conductscience.org/library/papers/26123412 | PubMed |
| 23139057 | Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. | Breast Cancer Res Treat | 2013 | https://conductscience.org/library/papers/23139057 | PubMed |
| 21274246 | Management of breast cancer: what do I tell the patient? | Can Fam Physician | 1986 | https://conductscience.org/library/papers/21274246 | PubMed |
| 20595533 | Meta-analysis as a manifestation of 'bondförnuft' ('peasant sense'). | J R Soc Med | 2010 | https://conductscience.org/library/papers/20595533 | PubMed |
| 18629447 | Types of bone metastases in women with breast cancer undergoing systemic treatments. | Radiol Med | 2008 | https://conductscience.org/library/papers/18629447 | PubMed |
| 17295093 | Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases? | Clin Exp Metastasis | 2007 | https://conductscience.org/library/papers/17295093 | PubMed |
| 7779726 | Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7779726 | PubMed |
| 7397944 | Antitumor drug toxicity in tumor-free and tumor-bearing mice. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7397944 | PubMed |
| 7362189 | Primary treatment of breast cancer by modified radical mastectomy, radiotherapy, and chemotherapy. | Ann R Coll Surg Engl | 1980 | https://conductscience.org/library/papers/7362189 | PubMed |
| 7265817 | Pathobiology of breast cancer: hypothesis of biological predetermination and long-term survival. | Klin Wochenschr | 1981 | https://conductscience.org/library/papers/7265817 | PubMed |
| 7228880 | The effect of chemotherapy on occult metastases after surgical removal of a non-immunogenic mouse carcinoma. | J Cancer Res Clin Oncol | 1980 | https://conductscience.org/library/papers/7228880 | PubMed |
| 7041939 | Preliminary results of primary systemic chemotherapy in association with surgery or radiotherapy in rapidly progressing breast cancer. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7041939 | PubMed |
| 7014886 | Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication. | J R Soc Med | 1980 | https://conductscience.org/library/papers/7014886 | PubMed |
| 7004560 | Adjuvant chemotherapy for breast cancer: side effects and quality of life. | Br Med J | 1980 | https://conductscience.org/library/papers/7004560 | PubMed |
| 6788145 | Breast cancer: a case for conservation. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6788145 | PubMed |
| 6784849 | Multimodal treatment in operable breast cancer: five-year results of the CMF programme. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6784849 | PubMed |
| 6772333 | Surgery plus adjuvant chemotherapy--a review of therapeutic implications. I. Breast cancer. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6772333 | PubMed |
| 6736112 | Estrogen receptor status and adjuvant polychemotherapy or antiestrogen therapy in patients with high-risk breast cancer. | J Cancer Res Clin Oncol | 1984 | https://conductscience.org/library/papers/6736112 | PubMed |
| 6708398 | Adjuvant chemotherapy of breast cancer: hope--reality--hazard? | Klin Wochenschr | 1984 | https://conductscience.org/library/papers/6708398 | PubMed |
| 3983039 | Controversies in the medical management of breast cancer. | Postgrad Med J | 1985 | https://conductscience.org/library/papers/3983039 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/326384
GET https://conductscience.org/api/papers/v1/326384/cited_by?page=2